Statistics

Total Visits

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.89

Select a period of time:

Number of views in the range

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.47

Views

Views
November 20259
December 20253
January 202610
February 20263
March 20269
April 20268
May 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States29
Brazil6
United Kingdom2
Venezuela2
Germany2
Côte d'Ivoire1
Egypt1
Finland1
Mexico1
Singapore1
 

Top cities views

Views
San Jose13
Ashburn7
10th of Ramadan City1
Barbacena1
Belo Horizonte1
Frankfurt am Main1
Grajales1
Helsinki1
Iporá1
Itabira1